Systemic sclerosis-associated pulmonary hypertension: why disease-specific composite endpoints are needed

Systemic sclerosis-associated pulmonary hypertension: why disease-specific composite endpoints are needed

Pulmonary arterial hypertension (PAH) is a serious complication of systemic sclerosis (SSc). In clinical trials PAH-SSc has been grouped with other forms, including idiopathic PAH. The primary endpoint for most pivotal studies was improvement in exercise capacity. However, composite clinical endpoin...

Full description

Bibliographic Details
Main Authors: Denton, Christopher P, Avouac, Jerome, Behrens, Frank, Furst, Daniel E, Foeldvari, Ivan, Humbert, Marc, Huscher, Doerte, Kowal-Bielecka, Otylia, Matucci-Cerinic, Marco, Nash, Peter, Opitz, Christian F, Pittrow, David, Rubin, Lewis J, Seibold, James R, Distler, Oliver
Format: Online
Language:English
Published: BioMed Central 2011
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218892/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218892/

Similar Items